Non-compliance with DOTPlus. Alternatively DOT can be done by telephoning patient on a daily basis 5 times a week and having patient annotate taking drug in a log which would be reviewed by clinic staff
History of being treated for tuberculosis in the prior 2 years unless there is DST, including PCR testing, showing sensitivity to rifamycin.
Known hypersensitivity to rifampin or rifabutin.
Liver enzymes greater than 2 times ULN.
Bilirubin greater than 2 times ULN.
Serum creatinine greater than 3 times ULN.
Hemoglobin less than 7.0 gms even if receiving erythropoietin.
Absolute neutrophil count less than 750 cells/mm3 even if receiving G-CSF.
Fasting triglycerides greater than 400 mg/dL.
Fasting cholesterol > 1.6 upper limits of normal.
GI intolerance of tuberculosis medications requiring discontinuation of tuberculosis medications.
Fasting glucose greater 150 mg/dL.
Pregnant women.
Use of one of the prohibited medications
Any condition that the investigators feel could compromise the use of the current medication.
Have a CD4 cell count of 50 cells/mm3or less
Hepatitis B or C infection
Alcohol or illicit drug use, which in the investigators opinion may affect participation in study.
